ENZY Enzymotec Ltd. - Ordinary Shares (delisted)

Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today announced that Mr. Erez Israeli, the Company’s Chief Executive Officer, will present at the Jefferies 2017 Global Healthcare Conference being held on June 6-9, 2017 at the Grand Hyatt New York in New York City.

Mr. Israeli is scheduled to present on Thursday, June 8, 2017 at 4:30 PM EDT. The presentation will take place in 7 Imperial. The presentation will be followed immediately by a breakout session at 5:00 PM EDT in the Booth Room.

Mr. Israeli and Mr. Oren Bryan, the Company’s Chief Financial Officer, will also be available to participate in one-to-one meetings with investors during the conference.

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies.

Contact

The Ruth Group
Tram Bui / Alexander Lobo
Phone: 646-536-7035 / 7037
tbui@theruthgroup.com
alobo@theruthgroup.com